Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lifecore Biomedical (LFCR) Shares Outstanding (Diluted Average): 2009-2025

Historic Shares Outstanding (Diluted Average) for Lifecore Biomedical (LFCR) over the last 17 years, with May 2025 value amounting to $34.8 million.

  • Lifecore Biomedical's Shares Outstanding (Diluted Average) fell 5.02% to $34.8 million in Q2 2025 from the same period last year, while for May 2025 it was $34.8 million, marking a year-over-year decrease of 5.02%. This contributed to the annual value of $34.8 million for FY2025, which is 5.02% down from last year.
  • As of FY2025, Lifecore Biomedical's Shares Outstanding (Diluted Average) stood at $34.8 million, which was down 5.02% from $36.7 million recorded in FY2024.
  • Lifecore Biomedical's 5-year Shares Outstanding (Diluted Average) high stood at $36.7 million for FY2024, and its period low was $29.3 million during FY2021.
  • Over the past 3 years, Lifecore Biomedical's median Shares Outstanding (Diluted Average) value was $34.8 million (recorded in 2025), while the average stood at $33.8 million.
  • In the last 5 years, Lifecore Biomedical's Shares Outstanding (Diluted Average) rose by 22.37% in 2024 and then declined by 5.02% in 2025.
  • Yearly analysis of 5 years shows Lifecore Biomedical's Shares Outstanding (Diluted Average) stood at $29.3 million in 2021, then rose by 0.59% to $29.5 million in 2022, then grew by 1.67% to $30.0 million in 2023, then rose by 22.37% to $36.7 million in 2024, then decreased by 5.02% to $34.8 million in 2025.